Odds ratio (95% CI) | P | |
---|---|---|
Sex (female vs. male) | 0.46 (0.18–1.22) | 0.119 |
Age (years) | 0.99 (0.96–1.03) | 0.690 |
Duration of symptoms (days) | 1.00 (0.99–1.01) | 0.660 |
Number of retinal breaks | 1.10 (0.64–1.91) | 0.730 |
With inferior retinal breaks in detached retina (yes vs. no) | 1.29 (0.51–3.24) | 0.593 |
With retinal break(s) ≥ 1.5 DD (yes vs. no) | 2.68 (1.04–6.92) | 0.041* |
Number of quadrants involved | 1.25 (0.75–2.08) | 0.389 |
Method to achieve retinopexy | ||
Laser photocoagulation | 1 [Reference] | |
Cryotherapy | 2.64 (0.83–8.43) | 0.102 |
Combined | 2.08 (0.44–9.96) | 0.359 |
PVR | ||
A | 1 [Reference] | |
B | 0.71 (0.17–2.94) | 0.636 |
C1 | 0.56 (0.03–9.48) | 0.685 |
Macular status (off vs. no) | 0.98 (0.37–2.61) | 0.966 |
Posterior vitreous detachment (yes vs. no) | 1.03 (0.42–2.55) | 0.951 |
Period for restricted activities (days) | 0.94 (0.89–0.99) | 0.020* |